CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-17 | Basta Steven L President and CEO | Grant or award | +62,038 | 145,288 | ||
| 2025-12-17 | Basta Steven L President and CEO | Shares withheld for taxes | −31,502 | $15.36 | $484K | 113,786 |
| 2025-11-28 | Basta Steven L President and CEO | Option exercise | +90,000 | 131,625 | ||
| 2025-11-28 | Basta Steven L President and CEO | Shares withheld for taxes | −48,375 | $15.62 | $756K | 83,250 |
| 2025-11-28 | Basta Steven L President and CEO | Option exercise · Performance Shares | −90,000 | 180,000 | ||
| 2025-11-03 | Breedlove Robert Charles Principal Accounting Officer | Sale | −524 | $13.51 | $7K | 47,407 |
| 2025-10-06 | Narula Sanjeev Chief Financial & Bus. Officer | Grant or award | +144,000 | 144,000 | ||
| 2025-10-06 | Narula Sanjeev Chief Financial & Bus. Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2025-09-25 | Basta Steven L President and CEO | Option exercise | +90,000 | 90,000 | ||
| 2025-09-25 | Basta Steven L President and CEO | Shares withheld for taxes | −48,375 | $11.66 | $564K | 41,625 |
| 2025-09-25 | Basta Steven L President and CEO | Option exercise · Performance Shares | −90,000 | 270,000 | ||
| 2025-09-05 | Breedlove Robert Charles Principal Accounting Officer | Sale | −461 | $12.09 | $6K | 47,931 |
| 2025-07-16 | Breedlove Robert Charles Principal Accounting Officer | Sale | −1,692 | $8.36 | $14K | 48,392 |
| 2025-06-23 | Cook Anne Marie Chief Legal Off. & Corp. Sec. | Grant or award · Stock Option (Right to Buy) | +210,000 | 210,000 | ||
| 2025-06-03 | KARBE FRANK Director | Grant or award | +10,500 | 67,500 | ||
| 2025-06-03 | KARBE FRANK Director | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2025-06-03 | COLA MICHAEL F Director | Grant or award | +10,500 | 39,798 | ||
| 2025-06-03 | COLA MICHAEL F Director | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 | ||
| 2025-06-03 | Topper James N Director | Grant or award | +10,500 | 42,596 | ||
| 2025-06-03 | Topper James N Director | Grant or award · Stock Option (Right to Buy) | +17,500 | 17,500 |
Page 3 of 19 · 379 trades